Loading insider details...
Latest Form 4 (May 15, 2026): Grant/Award of 2,047 VTR shares, $184.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 15, 2026 | Ventas, Inc. (VTR) | Grant/Award | 2,047 | $184.9K |
| Jan 27, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Sale | 136,789 | $649.7K |
| Jan 14, 2026 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 1,008,000 | n/a |
| May 15, 2025 | Ventas, Inc. (VTR) | Grant/Award | 2,882 | $185.0K |
| Jan 3, 2025 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 892,500 | n/a |
| May 16, 2024 | Ventas, Inc. (VTR) | Grant/Award | 3,648 | $175.0K |
| Jan 4, 2024 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 1,184,688 | n/a |
| Dec 18, 2023 | Taysha Gene Therapies, Inc. (TSHA) | Grant/Award | 466,550 | n/a |
| Aug 17, 2023 | Taysha Gene Therapies, Inc. (TSHA) | Purchase | 444,444 | $400.0K |
| May 18, 2023 | Ventas, Inc. (VTR) | Grant/Award | 3,835 | $175.0K |